BIO vs MVIS · rev $2.58B vs rev $2.4M
BIO (BIO) versus Microvision Inc (MVIS) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Microvision Inc (MVIS) is a scientific & technical instruments company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 287.0% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported MVIS revenue for 2026-06-30 was $2.4M. Net income was -$62.2M. MVIS currently screens at market cap $200.4M.
BIO currently screens at market cap $0. MVIS currently screens at market cap $200.4M.
Not investment advice. Open the BIO and MVIS stock pages for the full models.
Not investment advice.